Tumor-triggered transformation of chimeric peptide for dual-stage-amplified magnetic resonance imaging and precise photodynamic therapy
Tumor-triggered transformation of chimeric peptide for dual-stage-amplified magnetic resonance imaging and precise photodynamic therapy
复制标题
用于双级放大磁共振成像和精确光动力治疗的嵌合肽的肿瘤触发转化
DOI:
10.1016/j.biomaterials.2018.08.026
复制
发表时间:
2018
期刊:
影响因子:
14
通讯作者:
Han He You
中科院分区:
文献类型:
--
作者:
Zhang Jin;Mu Yong Li;Ma Zhao Yu;Han Kai;Han He You
Despite the great success in clinical magnetic resonance imaging (MRI), Gd3+-based contrast agents still suffer from low proton relaxation efficiency, rapid metabolic clearance as well as poor sensitivity. In this work, we designed a matrix metalloproteinase-2 (MMP-2) responsive chimeric peptide for dual-stage-amplified MRI and precise photodynamic therapy. Bothin vitroandin vivostudies indicated that this chimeric peptide could self-assembly into spherical nanoparticles at physiological condition with r1value of 28.17 mM−1s−1. Meanwhile, the spherical shape endowed chimeric peptide with efficient tumor accumulationviaenhanced penetration and retention (EPR) effect. Importantly, the overexpressed MMP-2 in tumor region could specifically hydrolyze chimeric peptide, leading to sphere-to-fiber transformation. This transformation enhanced both the tumor accumulation and the relaxivity of contrast agent. Consequently, the r1value was remarkably elevated to 51.52 mM−1s−1, which guided precise photodynamic therapy. This tumor microenvironment-triggered transformable strategy should show great potential for tumor-targeted imaging and phototherapy.